through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
More
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
Introduction Not all carbohydrates are created equal. While a slice of white bread and a bowl of oatmeal may contain similar amounts of carbohydrates, their effects on your blood sugar can be dramatically different. This is where the glyc...
The term "pulse oscillation" resonates across multiple domains within Apple’s iOS ecosystem—from respiratory medicine and display technology to haptic feedback and health monitoring. This article provides a beginner-...
Imagine a test so simple that a single breath can reveal the hidden inflammation brewing deep inside your lungs. That is the promise of fractional exhaled nitric oxide (FeNO)—a biomarker that has quietly revolutionized how doctors d...
Please complete the form to contact our team